ibritumomab tiuxetan

DNA damage inducible transcript 3 ; Homo sapiens







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 25395425 Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313. 2015 Jan 8 1
2 20542986 Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients. 2010 Aug 1 2